Cassady Schiller Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Cassady Schiller Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$188K	Buy	3,319 +125	+4%	+$6.98K	0.07%	122
2024 Q3	$165K	Hold	3,194	–	–	0.06%	130
2024 Q2	$133K	Buy	3,194 +200	+7%	+$8.95K	0.05%	137
2024 Q1	$162K	Buy	2,994 +1	+0%	+$51	0.07%	131
2023 Q4	$154K	Sell	2,993 -307	-9%	-$16.1K	0.08%	128
2023 Q3	$192K	Sell	3,300 -200	-6%	-$12.3K	0.11%	102
2023 Q2	$224K	Hold	3,500	–	–	0.12%	98
2023 Q1	$243K	Hold	3,500	–	–	0.11%	91
2022 Q4	$252K	Sell	3,500 -962	-22%	-$72.5K	0.15%	88
2022 Q3	$317K	Buy	4,462 +654	+17%	+$47.4K	0.18%	80
2022 Q2	$293K	Sell	3,808 -378	-9%	-$28.8K	0.15%	75
2022 Q1	$306K	Buy	4,186 +203	+5%	+$13.6K	0.15%	86
2021 Q4	$248K	Buy	+3,983	New	+$234K	0.15%	88

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cassady Schiller Wealth Management's BMY Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3.9% in Q4 2024, buying an estimated $6.98K and bringing the position to 3,319 shares worth $188K. The position accounts for 0.07% of the portfolio, ranked #122.

Cassady Schiller Wealth Management first reported a position in BMY in Q4 2021 and has held it in 13 quarters since. The position peaked at $317K in Q3 2022. 2,494 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Cassady Schiller Wealth Management held 3,319 shares of Bristol-Myers Squibb worth $188K as of Q4 2024.
Cassady Schiller Wealth Management bought 125 Bristol-Myers Squibb shares in Q4 2024, an estimated $6.98K.
Bristol-Myers Squibb made up 0.07% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #122 holding.
Cassady Schiller Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 13 quarters since.
Cassady Schiller Wealth Management's Bristol-Myers Squibb position peaked at $317K in Q3 2022.
2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.